H Pylori Urease Controls, Positive, 2mL Dropper Bottle (IDC73) Lift Slings simultaneous qualitative detection and differentiation

simultaneous qualitative detection and differentiation of influenza A and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 by their healthcare provider within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests

Inside Base Area: 10-1/2” at widest end and 5-1/2” at narrow end

8 Hour Stability of results

non-porous surfaces

Total Case Quantity 480

H Pylori Urease Controls, Positive, 2mL Dropper Bottle (IDC73) Lift Slings simultaneous qualitative detection and differentiationACCUTEST Urease Glycerin Controls Solution, 2 mL Dropper Bottle H. pylori is a major cause of diseases of the gastrointestinal tract. Eradication of the infection in individuals will improve symptoms including dyspepsia, gastritus and gastric ulcers, and may prevent gastric cancer. While there are several methods of detecting H. pylori, biopsy testing using rapid urease is considered to be the Gold Standard for detecting active H. pylori infections.